Adis JournalsBrowse
Summary Slide.png (71.79 kB)
Download file

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Diabetic Macular Edema Patients: Protocol for a Multicenter, Randomized Controlled, Open-Label Trial

Download (71.79 kB)
media
posted on 11.06.2020, 11:59 authored by Ryoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, Tomoaki Tatsumi, Sho Takahashi, Kengo Nagashima, Noriko Asaumi, Miyuki Arai, Fumio Shimada, Kaori Tachibana, Yoshihiro Watanabe, Ko Ishikawa, Akiko Hoshino, Kyohei Yamamoto, Mariko Kubota-Taniai, Takafumi Mayama, Shuichi Yamamoto, Koutaro Yokote

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

Usage metrics

Read the peer-reviewed publication

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Diabetic Macular Edema Patients: Protocol for a Multicenter, Randomized Controlled, Open-Label Trial
Diabetes TherapyDiabetes Therapy

Categories

Keywords

Anti-vascular endothelial growth factor agentCentral retinal thicknessDiabetic macular edemaGlucose co-transporter 2 inhibitorOptical coherence tomography

Licence

CC BY-NC 4.0

Exports